Reproductive Health Devices are used to manage conditions related to the reproductive system, its functions and processes. The Reproductive Health Devices include Endometrial Ablation Devices, Female Sterilization Devices, Reversible Contraceptive Devices, Assisted Reproductive Technology (ART) Devices, and Postpartum Hemorrhage Control Devices. Reversible Contraceptive Devices are used as birth control to prevent unwanted pregnancy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the reversible contraceptive devices devices market, including market shares of different players within the UK. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the reversible contraceptive devices market in the UK was Bayer followed by Organon, Shanghai Dahua Pharmaceuticals, HLL Lifecare, CooperSurgical, Allergan Aesthetics, Kessel Marketing & Vertriebs, Pregna International and Meril Life Sciences.
Reversible Contraceptive Devices are inserted or implanted into women of child-bearing age, often for long periods of time. Intrauterine Devices (IUDs), Diaphragms and Hormonal Implants are tracked under Reversible Contraceptive Devices.
The value of the reversible contraceptive devices devices market within the UK was expected to be over $20m in 2023.
For the latest complete market share analysis of reversible contraceptive devices device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.